{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2021, Part 1
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- List characteristics of four new medications for migraines.
- Identify features of a new medication for the treatment of insomnia.
- Identify features of a new medication for the treatment of hypercholesterolemia.
- Identify features of a new medication for the treatment of psychosis.
Disclosures
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$24.95
Credits:
- ANCC 2.5 CH / 2.5 APH
- DC - BON 2.5 CH
- FL - BON 2.5 CH
- GA - BON 2.5 CH
Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: N0221A
Published: Feb 2021
Expires: 12/6/2024
Sources:
Nursing2024
Required Passing Score: 8/10 (80%)